Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.47B

Market cap31.47B

Price-Earnings ratio

12.64

Price-Earnings ratio12.64

Dividend yield

2.70%

Dividend yield2.70%

Average volume

6.85M

Average volume6.85M

High today

$76.06

High today$76.06

Low today

$73.80

Low today$73.80

Open price

$75.11

Open price$75.11

Volume

4.77M

Volume4.77M

52 Week high

$161.77

52 Week high$161.77

52 Week low

$71.47

52 Week low$71.47

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $75.50. The company's market cap stands at 31.47B, with a P/E ratio of 12.64 and a dividend yield of 2.70%.

On 2026-07-09, Zoetis(ZTS) stock moved within a range of $73.80 to $76.06. With shares now at $75.50, the stock is trading +2.3% above its intraday low and -0.7% below the session's peak.

Trading volume for Zoetis(ZTS) stock has reached 4.77M, versus its average volume of 6.85M.

The stock's 52-week range extends from a low of $71.47 to a high of $161.77.

ZTS News

MarketWatch 1d

Zoetis Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

...

TipRanks 2d

Zoetis granted EC Marketing Authorization for Poulvac Procerta vaccine

Zoetis (ZTS) announced that the European Commission, or EC, has granted marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine for th...

TipRanks 3d

Zoetis put volume heavy and directionally bearish

Bearish flow noted in Zoetis (ZTS) with 3,163 puts trading, or 1.6x expected. Most active are Sep-26 65 puts and Sep-26 70 puts, with total volume in those stri...

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

47.6%

Sell

More ZTS News

Simply Wall St 6d

Should Zoetis’ Shift Into Russell Midcap Indexes After Weaker Guidance Require Investor Action?

In late June 2026, Zoetis Inc. was removed from several Russell Top 200 indexes and added to the Russell Midcap, Midcap Value, and Midcap Growth benchmarks foll...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.